NCT02877914

Brief Summary

This study will use a two-stage random sampling design to create a nationally representative sample of patients with heart failure (HF) in China. The investigators sought to describe the clinical profiles, to assess treatment patterns and in-hospital outcomes for HF, and to identify targets for care quality improvement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 24, 2016

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

December 6, 2017

Status Verified

December 1, 2017

Enrollment Period

1.6 years

First QC Date

August 16, 2016

Last Update Submit

December 4, 2017

Conditions

Heart Failure

Keywords

heart failure, retrospective

Outcome Measures

Primary Outcomes (1)

  • Death

    Duration of hospitalization, an average of 10 days

Interventions

Observational studyOTHER

This is a non-interventional study, patients receive their usual treatment as determined by the physician.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient with primary reason for admission of heart failure, aged 18 years or above

You may qualify if:

  • Patients with heart failure as the primary reason for hospitalization, including both new-onset HF or decompensation of chronic HF。
  • Hospitalized during January 1st, 2015 to December 31st, 2015
  • Aged 18 years or above

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhengzhou People's Hospital

Zhengzhou, China

RECRUITING

Related Publications (4)

  • Yu Y, Guan W, Masoudi FA, Wang B, He G, Spertus JA, Lu Y, Krumholz HM, Li J. Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China-The China PEACE Retrospective Heart Failure Study. J Am Heart Assoc. 2022 Oct 4;11(19):e026300. doi: 10.1161/JAHA.122.026300. Epub 2022 Sep 29.

    PMID: 36172964DERIVED

  • Yu Y, Gupta A, Wu C, Masoudi FA, Du X, Zhang J, Krumholz HM, Li J; China PEACE Collaborative Group. Characteristics, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: The China PEACE Retrospective Heart Failure Study. J Am Heart Assoc. 2019 Sep 3;8(17):e012884. doi: 10.1161/JAHA.119.012884. Epub 2019 Aug 21.

    PMID: 31431117DERIVED

  • Yu Y, Spatz ES, Tan Q, Liu S, Lu Y, Masoudi FA, Schulz WL, Krumholz HM, Li J; China PEACE Collaborative Group. Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study. J Am Heart Assoc. 2019 Aug 6;8(15):e012776. doi: 10.1161/JAHA.119.012776. Epub 2019 Jul 31.

    PMID: 31364457DERIVED

  • Yu Y, Zhang H, Li X, Lu Y, Masoudi FA, Krumholz HM, Li J. The China Patient-centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective heart failure study design. BMJ Open. 2018 May 10;8(5):e020918. doi: 10.1136/bmjopen-2017-020918.

    PMID: 29748344DERIVED

MeSH Terms

Conditions

Heart Failure

Interventions

Observation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Jing Li, MD, PhD

    China National Center for Cardiovascular Disease

    PRINCIPAL INVESTIGATOR

  • Harlan M Krumholz, MD, SM

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jing Li, MD, PhD

CONTACT

+86 (10) 6086 6077jing.li@fwoxford.org

Yuan Yu, MD

CONTACT

+86 17801013954yuan.yu@fwoxford.org

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2016

First Posted

August 24, 2016

Study Start

September 1, 2016

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

December 6, 2017

Record last verified: 2017-12

Locations

CN(1)